ALEXANDRA SHEPPARD: Open Payments
NPI 1841651841 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 8 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $212 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $102 |
| Amgen Inc. | 1 | $101 |
| Lilly USA, LLC | 1 | $99 |
| Novo Nordisk Inc | 2 | $95 |
| Dexcom, Inc. | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: AIRSUPRA, REPATHA, ZEPBOUND, Dexcom G6 Transmitter, ACCRUFER, CUVITRU.
Industry payments across NC — which companies pay providers there.
